Boston Scientific Corp.
(NYSE : BSX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.14%107.570.6%$463.76m
TMOThermo Fisher Scientific Inc.
1.11%283.771.0%$450.58m
ABTAbbott Laboratories
-0.26%79.610.8%$313.34m
ISRGIntuitive Surgical, Inc.
1.33%518.032.4%$291.82m
BSXBoston Scientific Corporation
0.66%38.231.1%$286.68m
EWEdwards Lifesciences Corporation
0.53%227.291.2%$251.89m
SYKStryker Corporation
1.17%213.761.3%$238.49m
BDXBecton, Dickinson and Company
1.77%252.951.1%$237.90m
ALGNAlign Technology, Inc.
3.09%200.166.3%$232.01m
BAXBaxter International Inc.
0.46%88.011.7%$226.86m
PODDInsulet Corporation
-0.98%153.396.9%$161.71m
ZBHZimmer Biomet Holdings, Inc.
1.77%136.441.7%$143.34m
WATWaters Corporation
1.17%213.774.0%$124.80m
PENPenumbra, Inc.
2.27%145.958.7%$110.33m
ABMDABIOMED, Inc.
4.50%169.643.3%$105.68m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.